➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Baxter
Medtronic
AstraZeneca
Boehringer Ingelheim

Last Updated: October 28, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for AVN-944

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug AVN-944?

AVN-944 is an investigational drug.

There have been 6 clinical trials for AVN-944. The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2007.

The most common disease conditions in clinical trials are Atrial Fibrillation, Osteonecrosis, and Necrosis. The leading clinical trial sponsors are University of Leeds, Sheba Medical Center, and Mayo Clinic.

Recent Clinical Trials for AVN-944
TitleSponsorPhase
Macitentan in Pulmonary Hypertension of Sickle Cell DiseaseActelionPhase 1
Macitentan in Pulmonary Hypertension of Sickle Cell DiseaseBoston UniversityPhase 1
The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients.University of LeedsN/A

See all AVN-944 clinical trials

Clinical Trial Summary for AVN-944

Top disease conditions for AVN-944
Top clinical trial sponsors for AVN-944

See all AVN-944 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Baxter
Medtronic
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.